Great Point Partners’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-134,612
| Closed | -$3.16M | – | 36 |
|
|
2024
Q2 | $3.16M | Buy |
134,612
+9,612
| +8% | +$226K | 0.61% | 31 |
|
|
2024
Q1 | $4.74M | Hold |
125,000
| – | – | 0.74% | 33 |
|
|
2023
Q4 | $2.69M | Buy |
+125,000
| New | +$2.69M | 0.46% | 30 |
|
|
2022
Q4 | – | Sell |
-100,000
| Closed | -$1.32M | – | 54 |
|
|
2022
Q3 | $1.32M | Hold |
100,000
| – | – | 0.32% | 39 |
|
|
2022
Q2 | $1.26M | Buy |
+100,000
| New | +$1.26M | 0.3% | 33 |
|
|
2022
Q1 | – | Sell |
-36,410
| Closed | -$4.32M | – | 40 |
|
|
2021
Q4 | $4.32M | Buy |
36,410
+410
| +1% | +$48.7K | 0.96% | 31 |
|
|
2021
Q3 | $7.16M | Hold |
36,000
| – | – | 1.67% | 27 |
|
|
2021
Q2 | $6.26M | Buy |
36,000
+15,884
| +79% | +$2.76M | 1.31% | 27 |
|
|
2021
Q1 | $3.98M | Buy |
+20,116
| New | +$3.98M | 0.82% | 27 |
|